Avalo Therapeutics Inc
(NAS:AVTX)
$
9.55
-0.44 (-4.4%)
Market Cap: 99.93 Mil
Enterprise Value: 18.62 Mil
PE Ratio: 0
PB Ratio: 4.39
GF Score: 47/100 Avalo Therapeutics Inc at Jefferies Next Generation IBD Therapeutics Summit (Virtual) - Pre-recorded Presentation Transcript
Oct 19, 2021 / 12:00PM GMT
Release Date Price:
$6451.2
(+1.36%)
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot